Israel Englander Innate Pharma Sa Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Innate Pharma Sa stock. As of the latest transaction made, Millennium Management LLC holds 10,579 shares of IPHA stock, worth $20,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,579

Previous 12,002 11.86%

Holding current value

$20,523

Previous $33,000 9.09%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.37 - $2.93 $3,372 - $4,169	-1,423 Reduced 11.86%	10,579 $30,000
Q4 2023 Feb 14, 2024	SELL	$2.17 - $2.93 $81,262 - $109,722	-37,448 Reduced 75.73%	12,002 $33,000
Q2 2023 Aug 14, 2023	SELL	$2.78 - $3.5 $34,608 - $43,571	-12,449 Reduced 20.11%	49,450 $152,000
Q1 2023 May 15, 2023	SELL	$2.67 - $3.86 $26,125 - $37,770	-9,785 Reduced 13.65%	61,899 $176,000
Q4 2022 Feb 14, 2023	BUY	$1.9 - $3.73 $108,395 - $212,796	57,050 Added 389.85%	71,684 $267,000

Q3 2022 Nov 14, 2022	SELL	$2.0 - $3.2 $4,444 - $7,110	-2,222 Reduced 13.18%	14,634 $29,000
Q2 2022 Aug 15, 2022	SELL	$2.0 - $3.55 $16,518 - $29,319	-8,259 Reduced 32.88%	16,856 $46,000
Q1 2022 May 16, 2022	SELL	$2.7 - $4.8 $80,746 - $143,548	-29,906 Reduced 54.35%	25,115 $84,000
Q4 2021 Feb 14, 2022	BUY	$4.34 - $6.06 $121,099 - $169,092	27,903 Added 102.89%	55,021 $252,000
Q3 2021 Nov 15, 2021	SELL	$3.04 - $8.1 $59,732 - $159,156	-19,649 Reduced 42.01%	27,118 $167,000
Q2 2021 Aug 16, 2021	SELL	$3.29 - $4.61 $9,761 - $13,677	-2,967 Reduced 5.97%	46,767 $155,000
Q1 2021 May 17, 2021	SELL	$4.09 - $4.83 $20,298 - $23,971	-4,963 Reduced 9.07%	49,734 $214,000
Q4 2020 Feb 16, 2021	SELL	$3.85 - $5.62 $69,146 - $100,935	-17,960 Reduced 24.72%	54,697 $224,000
Q1 2020 May 14, 2020	SELL	$3.8 - $7.95 $6,023 - $12,600	-1,585 Reduced 2.13%	72,657 $485,000
Q4 2019 Feb 14, 2020	BUY	$5.66 - $6.55 $420,209 - $486,285	74,242 New	74,242 $477,000

Others Institutions Holding IPHA

# of Institutions

Shares Held

254K

Call Options Held

Put Options Held

View Full List

About Innate Pharma SA

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $155M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

More about IPHA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account